Clinical TrialsSearch results for "cytarabine"
Number of results: 7
Other
- A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreated, High-intermediate and High-risk Patients With Newly-diagnosed Diffuse Large B-cell Lymphoma (DLBCL)
- Diffuse Large B-cell Lymphoma
- Ueda Eiji
- 2022-06-24
Other
- Treatment protocol for acute promyelocytic leukemia -FBMTG-APL2009-
- acute promyelocytic leukemia
- Fukuoka Blood & Marrow Transplant Group
- 2009-03-01
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-P05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL)
- Acute promyelocytic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2007-03-19
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose <em>Cytarabine</em> With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study)
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2005-09-12
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or <em>cytarabine</em> ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
- 1